The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126141271 12614127 1 I 2016 20160724 20160802 20160802 EXP US-JNJFOC-20160720296 JANSSEN 56.80 YR A F Y 47.63000 KG 20160802 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126141271 12614127 1 SS GALANTAMINE HBR GALANTAMINE HYDROBROMIDE 1 Oral OFF THE MEDICATION FOR 6 DAYS Y U 0 12 MG TABLETS BID
126141271 12614127 2 SS GALANTAMINE HBR GALANTAMINE HYDROBROMIDE 1 Oral Y U 0 12 MG TABLETS QD
126141271 12614127 3 SS GALANTAMINE HBR GALANTAMINE HYDROBROMIDE 1 Oral Y U 0 12 MG TABLETS
126141271 12614127 4 SS GALANTAMINE HBR GALANTAMINE HYDROBROMIDE 1 Oral Y U 0 12 MG TABLETS QD
126141271 12614127 5 SS GALANTAMINE HBR GALANTAMINE HYDROBROMIDE 1 Oral FOR 2 DAYS Y U 0 12 MG TABLETS
126141271 12614127 6 SS GALANTAMINE HBR GALANTAMINE HYDROBROMIDE 1 Oral Y U 0 12 MG TABLETS QD
126141271 12614127 7 SS GALANTAMINE HBR GALANTAMINE HYDROBROMIDE 1 Oral DAY AND A HALF Y U 0 6 MG TABLETS BID
126141271 12614127 8 PS GALANTAMINE HBR GALANTAMINE HYDROBROMIDE 1 Oral Y U 21169 12 MG TABLETS BID
126141271 12614127 9 I DIPHENHYDRAMINE. DIPHENHYDRAMINE 1 Unknown U U 999999 UNSPECIFIED
126141271 12614127 10 SS LEVETIRACETAM. LEVETIRACETAM 1 Unknown U 0 7 MMOL UNSPECIFIED
126141271 12614127 11 SS LEVETIRACETAM. LEVETIRACETAM 1 Unknown U 0 8 ML UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126141271 12614127 1 Dementia Alzheimer's type
126141271 12614127 2 Dementia Alzheimer's type
126141271 12614127 3 Dementia Alzheimer's type
126141271 12614127 4 Dementia Alzheimer's type
126141271 12614127 5 Dementia Alzheimer's type
126141271 12614127 6 Dementia Alzheimer's type
126141271 12614127 7 Dementia Alzheimer's type
126141271 12614127 8 Dementia Alzheimer's type
126141271 12614127 9 Insomnia
126141271 12614127 10 Product used for unknown indication
126141271 12614127 11 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126141271 12614127 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126141271 12614127 Confusional state
126141271 12614127 Drug interaction
126141271 12614127 Drug intolerance
126141271 12614127 Inappropriate schedule of drug administration
126141271 12614127 Insomnia
126141271 12614127 Seizure
126141271 12614127 Somnolence
126141271 12614127 Weight decreased
126141271 12614127 Wrong technique in product usage process

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126141271 12614127 1 201605 0
126141271 12614127 2 20160722 20160722 0
126141271 12614127 3 20160720 20160721 0
126141271 12614127 4 20160723 20160723 0
126141271 12614127 5 2016 2016 0
126141271 12614127 6 2016 2016 0
126141271 12614127 7 2016 2016 0
126141271 12614127 8 2016 2016 0
126141271 12614127 9 201605 0